Abstract: The disclosure relates to a substantially uniform molecular sieve having MFI topology and quasi parallelepiped morphology. This disclosure also relates to a method of making the crystalline molecular sieve of this disclosure.

Abstract: This disclosure relates to a crystalline molecular sieve comprising silicalite-1 having substantially hexagonal column morphology of at least 90% and having less than 20% crystal twinning as measured by SEM. This disclosure also relates to a method of making the crystalline molecular sieve of this disclosure, the method comprises: (a) providing a mixture comprising at least one source of at least one tetravalent element (Y), at least one source of hydroxide ion, at least one directing-agent (R), water, the mixture having the following molar composition: H2O/Y=10 to 1000 OH?/Y=0.41 to 0.74 R/Y=0.001 to 2 wherein R comprises at least one of TPAOH, TPACl, TPABr, TPAI, and TPAF, wherein OH?/Y is not corrected for trivalent ion; (b) submitting the mixture at crystallization conditions to form a product comprising the crystalline molecular sieve, wherein the crystallization conditions comprise a temperature in the range of from 100° C. to 250° C.

Abstract: The invention describes a new class of crystalline silica material having two levels or porosity and structural order. At the first level, building units are nanoslabs of uniform size having zeolite framework. At the second structural level, nanoslabs are assembled, e.g. linked through their corners, edges or faces following patterns imposed by interaction with cationic surfactant or triblock copolymer molecules. After evacuation of these molecules, microporosity is obtained inside the nanoslabs, and a precise mesoporosity between the nanoslabs depending on the tiling pattern of the zeolite nanoslabs, as evidenced by X-ray diffraction. These materials are useful for the fixation of biologically active species, such as poorly soluble drugs.